Cannabis Life Sciences is the developer of a proprietary patent-pending extraction and conversion methodology that has potential to increase both yield and quality of cannabinoid oils extracted from cannabis plants. CLS is currently operating in the Nevada market through Oasis Cannabis, one of the top dispensaries in the state, and has definitive agreements to enter two Massachusetts assets by the end of 2019. In the booming cannabis market, opportunities continue to arise, and team at CLS is well positioned to execute.
CLS stands for "Cannabis Life Sciences," in recognition of our patent-pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS Holdings has recently received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology.
*Industry forecast for sales in 2021 per Forbes
The Oasis warehouse includes 18,000 square feet of dedicated space allocated to cultivation. Our phased approach allows us to expand rapidly and grow with market demand.